Who Paid My Doc
Deeann Davidson
Colon & Rectal Surgery New York, NY Nurse Practitioner
NPI 1407943509 CMS profile 688530
525 E 68Th St, New York, NY 10021
General payments
$4
Research payments
$0
Ownership & investment interest
$0
Through program year 2021, Deeann Davidson of New York, NY is reported in the CMS Open Payments database as having received $4 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 1st percentile of Colon & Rectal Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2021 | General | $4 | 1 |
Beside peers
- Deeann Davidson
- Colon & Rectal Surgery median
- Middle half of Colon & Rectal Surgery
- National median
In program year 2025, general payments to Deeann Davidson were reported at $0. Among 1,481 Colon & Rectal Surgery profiles paid that year, the median was $317 and the middle half received between $109 and $1,248.
Show as a table
| Year | Deeann Davidson | Colon & Rectal Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $443 | $125–$2,179 | $163 |
| 2020 | $0 | $167 | $53–$931 | $114 |
| 2021 | $4 | $207 | $72–$1,272 | $132 |
| 2022 | $0 | $341 | $111–$1,587 | $149 |
| 2023 | $0 | $322 | $115–$1,420 | $160 |
| 2024 | $0 | $328 | $112–$1,354 | $164 |
| 2025 | $0 | $317 | $109–$1,248 | $169 |
Breakdown
Prescribing to Medicare patients
Part D · data year 2024 · 1 drugPart D claims
11
Drug cost
$61
Branded share of claims
0%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Pantoprazole Sodium | Generic | 11 | $61 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Colon & Rectal Surgery in New York
David Rivadeneira
Colon & Rectal Surgery · Woodbury, NY
Jerald Wishner
Colon & Rectal Surgery · Mount Kisco, NY
Sanghyun Kim
Colon & Rectal Surgery · New York, NY
Ziad Kronfol
Colon & Rectal Surgery · West Nyack, NY
Lynn Oconnor
Colon & Rectal Surgery · Huntington, NY
Mehraneh Jafari
Colon & Rectal Surgery · New York, NY
Related records
Colon & Rectal Surgery in New York
Practitioners in the same specialty and state, ranked by reported value.
All Colon & Rectal Surgery
Everyone recorded under this specialty, nationwide.
Doctors in New York
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.